Home 
FOR AUTHORS Bratislava Medical Journal 2021 Bratislava Medical Journal Vol.122, No.1, p.11–17,2021
FOR AUTHORS Bratislava Medical Journal 2021 Bratislava Medical Journal Vol.122, No.1, p.11–17,2021
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.122, No.1, p.11–17,2021 |
||
| Title: COVID-19 molecular level laboratory diagnoses | ||
| Author: M. Pohanka | ||
| Abstract: Abstract AIMS: Aims: The Coronavirus Disease 2019 (COVID-19) caused not only global pandemic, but it also pointed at unprepared health care systems and countermeasures were introduced under the pressure of urgent circumstances. This review is focused on discussion and critical evaluation of instrumental tools for COVID-19 diagnosis that were developed in the last months. METHODS: Survey of actual literature and scientific reports was made. The most substantial analytical and diagnostical methods were identified and described. Principles and limitations of the methods are described, and actual papers are cited in this review. RESULTS: Analytical and diagnostical methods like Polymerase Chain Reaction (PCR), Loop-mediated isothermal Amplification (LAMP), Lateral Flow Immunochromatography Assay (LFIA), Enzyme-Linked Immunosorbent Assay (ELISA), biosensors and ChemiLuminescence ImmunoAssay (CLIA) are discussed for assay of viral particles, antigens and specific host antibodies in blood, serum, plasma, nasopharyngeal swab and other samples in order to diagnose COVID-19. CONCLUSIONS: The Coronavirus Disease 2019 (COVID-19) is an emerging disease that has spread over the world since the end of year 2019. The global epidemic pointed at the necessity to introduce sensitive methods for instrumental diagnosis of COVID-19 and distinguishing it from the other viral diseases. (Tab. 2, Ref. 96). |
||
| Keywords: antibody, biosensor, COVID-19, Coronavirus Disease 2019, diagnosis, enzyme-linked immunosorbent assay, ELISA, immunoassay, polymerase chain reaction, severe acute respiratory syndrome coronavirus 2, SARS-CoV-2 | ||
| Published online: 22-Dec-2020 | ||
| Year: 2021, Volume: 122, Issue: 1 | Page From: 11, Page To: 17 | |
| doi:10.4149/BLL_2021_025 |
||
|
|
 download file |
|